Metabolic Consequences of Glucagon-Like Peptide-1 Receptor Agonist Shortage: Deterioration of Glycemic Control in Type 2 Diabetes.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Metabolic Consequences of Glucagon-Like Peptide-1 Receptor Agonist Shortage: Deterioration of Glycemic Control in Type 2 Diabetes.
- Published In:
- Endocrinology and metabolism (Seoul, Korea), 40(1), 156-160 (2025)
- Authors:
- Choe, Hun Jee, Nauck, Michael A(8), Moon, Joon Ho
- Database ID:
- RPEP-10466
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10466APA
Choe, Hun Jee; Nauck, Michael A; Moon, Joon Ho. (2025). Metabolic Consequences of Glucagon-Like Peptide-1 Receptor Agonist Shortage: Deterioration of Glycemic Control in Type 2 Diabetes.. Endocrinology and metabolism (Seoul, Korea), 40(1), 156-160. https://doi.org/10.3803/EnM.2024.2150
MLA
Choe, Hun Jee, et al. "Metabolic Consequences of Glucagon-Like Peptide-1 Receptor Agonist Shortage: Deterioration of Glycemic Control in Type 2 Diabetes.." Endocrinology and metabolism (Seoul, 2025. https://doi.org/10.3803/EnM.2024.2150
RethinkPeptides
RethinkPeptides Research Database. "Metabolic Consequences of Glucagon-Like Peptide-1 Receptor A..." RPEP-10466. Retrieved from https://rethinkpeptides.com/research/choe-2025-metabolic-consequences-of-glucagonlike
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.